Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rates and Impact of Serious Adverse Events after Endovascular Thrombectomy among Large Vessel Occlusion Stroke Patients.
Lei B, Yang S, Tian L, Zhou S, Nguyen TN, Abdalkader MK, Liu X, Sun Y, Zhao N, Han Q, Mao A, Tao Z, Wang Y, Cao W, Yang S, Zhang J, Guo F, Wen H, Zhang J, Yue C, Yang J, Sang H, Qiu Z, Jin Y, Luo W. Lei B, et al. Among authors: mao a. Neuroepidemiology. 2024 Aug 12:1-12. doi: 10.1159/000540555. Online ahead of print. Neuroepidemiology. 2024. PMID: 39134004
Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion.
Sang H, Li F, Yuan J, Liu S, Luo W, Wen C, Zhu Q, Chen W, Lin M, Qi L, Zhong Y, Wang Z, Ling W, Shi Z, Chen H, Liu W, Liu Z, Yao X, Xiong F, Zeng G, Hu X, Dong H, Mao A, Yang G, Huang J, Chen L, Gong Z, Tao J, Liu H, Wu D, Qiu Z, Yang Q, Zi W, Li F. Sang H, et al. Among authors: mao a. Stroke. 2021 Mar;52(3):811-820. doi: 10.1161/STROKEAHA.120.031371. Epub 2021 Feb 11. Stroke. 2021. PMID: 33567874
Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Sang H, Huang J, Jiang B, Guo Q, Nguyen TN, Abdalkader M, Han Q, Zhou S, Tao Z, Mao A, Yan Z, Du J, Jin Y, Huang C, Liu T, Zhao W, Gu G, Wang L, Liu S, Luo S, Pu J, Hu J, Yang J, Li F, Zi W, Hu X, Qiu Z. Sang H, et al. Among authors: mao a. J Neurol. 2023 Apr;270(4):2246-2255. doi: 10.1007/s00415-023-11579-4. Epub 2023 Jan 25. J Neurol. 2023. PMID: 36697890 Clinical Trial.
Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials.
Sang H, Cao Z, Du J, Nguyen TN, Saver JL, Mao A, Nogueira RG, Tao Z, Zhou S, Han Q, Sun D, Lei B, Liu S, Zeng G, Yin C, Xie D, Luo W, Jin Z, Qiu Z; DEVT and RESCUE BT Trial Investigators. Sang H, et al. Among authors: mao a. Stroke. 2024 Apr;55(4):856-865. doi: 10.1161/STROKEAHA.123.044562. Epub 2024 Feb 16. Stroke. 2024. PMID: 38362756
Effect of Intravenous Tirofiban Versus Placebo on First-Pass Successful Reperfusion in Endovascular Stroke Thrombectomy: Insights From the RESCUE BT Randomized Clinical Trial.
Yuan J, Ge H, Tao Z, An H, Han Q, Saver JL, Nguyen TN, Zhou S, Mao A, Wu Y, Nogueira RG, Sun Y, Jiang S, Wei L, Fu X, Bai Y, Yang S, Hu W, Zhang G, Pan C, Zhang S, Qiao L, Chen Q, Sang H, Qiu Z, Wu F, Chang M, Ruan Z. Yuan J, et al. Among authors: mao a. J Am Heart Assoc. 2024 Nov 5;13(21):e036350. doi: 10.1161/JAHA.124.036350. Epub 2024 Nov 4. J Am Heart Assoc. 2024. PMID: 39494598 Free article. Clinical Trial.
Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies.
Torres-Yaghi Y, Qian J, Cummings H, Shimoda H, Ito S, Batson S, Mitchell S, Pagan F. Torres-Yaghi Y, et al. Clin Neuropharmacol. 2025 Jan-Feb 01;48(1):7-12. doi: 10.1097/WNF.0000000000000620. Clin Neuropharmacol. 2025. PMID: 39805118
Relative to istradefylline, dopamine agonists and catechol-O-methyl transferase (COMT) inhibitors had statistically significant higher odds of dyskinesia and somnolence. Monoamine oxidase-B inhibitors had significantly higher odds of hypotension. Amantadine extended …
Relative to istradefylline, dopamine agonists and catechol-O-methyl transferase (COMT) inhibitors had statistically significant higher odds …
Managing depression in the elderly: real-world clinical considerations and perspectives.
Kasper S, Incalzi RA, Bozzali M, Morgado P, Siwek M. Kasper S, et al. Int Clin Psychopharmacol. 2025 Jan 9. doi: 10.1097/YIC.0000000000000577. Online ahead of print. Int Clin Psychopharmacol. 2025. PMID: 39803748
Selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors were also commonly prescribed, while tricyclic antidepressants and monoamine oxidase inhibitors were less favored. Psychiatric conditions and sleep disturbances significantly inf …
Selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors were also commonly prescribed, while tricyclic antid …
QTL-Based Evidence of Population Genetic Divergence in Male Territorial Aggressiveness of the Japanese Freshwater Threespine Stickleback.
Yamazaki H, Mori S, Kishida O, Nagano AJ, Kokita T. Yamazaki H, et al. Ecol Evol. 2025 Jan 9;15(1):e70795. doi: 10.1002/ece3.70795. eCollection 2025 Jan. Ecol Evol. 2025. PMID: 39803187 Free PMC article.
Two notable behavior-related genes, HTR2A and MAO-A, are found near this locus. These genes have often been suggested to influence of aggressive behavior in animals; therefore, they are regarded as important candidate genes for further functional analyses. ...
Two notable behavior-related genes, HTR2A and MAO-A, are found near this locus. These genes have often been suggested to influ …
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data.
Nikolcheva T, Pagano G, Pross N, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Seppi K, Monnet A, Shariati N, Ricci B, Rutten-Jacobs L, Respondek G, Kustermann T, Taylor KI, Trundell D, Fontoura P, Doody R, Svoboda H, Bonni A; PADOVA Investigators and Prasinezumab Study Group. Nikolcheva T, et al. Parkinsonism Relat Disord. 2024 Dec 29;132:107257. doi: 10.1016/j.parkreldis.2024.107257. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 39798255 Free article.
INTRODUCTION: Prasinezumab was shown to potentially delay motor progression in individuals with early-stage Parkinson's disease (PD) who were either treatment-naive or on monoamine oxidase type B inhibitor (MAO-Bi) therapy in the PASADENA study. We report the ration …
INTRODUCTION: Prasinezumab was shown to potentially delay motor progression in individuals with early-stage Parkinson's disease (PD) who wer …
26,555 results
You have reached the last available page of results. Please see the User Guide for more information.